benoxinate hydrochloride; fluorescein sodium · Bausch Lomb Ireland · NDA 211039
Fluorescein Sodium And Benoxinate Hydrochloride
Earliest generic entry, as listed
15 Nov 2037
Blocked by patent: US 10293047, US 10632197, US 10842872.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10293047 | product, use U-2755 | 15 Nov 2037 |
| US 10632197 | product, use U-2755 | 15 Nov 2037 |
| US 10842872 | use U-3001 | 15 Nov 2037 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 211039 · 001 · RLD | solution/drops, ophthalmic | 0.4%;0.3% | 15 Nov 2037 |